EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Diabetes Technology & Therapeutics

ISSN 1520-9156 · SAGE Publications

Neueste Artikel

  1. The 2024 National Report on Continuous Glucose Monitoring Uptake in Pediatric Type 1 Diabetes Following Universal Funding in Aotearoa New Zealand: Early Findings from the KiwiDiab Pediatric Diabetes Network

    Hannah Allison, Jonathan Williman, Martin de Bock, Mercedes Burnside, Ben Wheeler, Vicki Cunningham, Fran Mouat, Maryam Mussa, Mark Shaw, Jeremy Armishaw, Rhian Teaz, Nicola Pereira, Oliver Grupp, Philip Moore, Pauline Giles, Esko Wiltshire, Gilli Lewis, Wendy Hunter, Erin Southgate, Ryan Paul, Hamish Crocket, Craig Jefferies, Rita Sigley, Sarah Beer

    Erschienen: 2026-11-02DOI: 10.1177/15209156261500903

  2. Safety and Effectiveness of MiniMed TM 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes

    Halis K. Akturk, Laura M. Nally, Rayhan A. Lal, Mark L. Warren, Carla Demeterco-Berggren, Gregory P. Forlenza, John “Chip” Reed, Dorothy I. Shulman, Mark S. Kipnes, Bruce W. Bode, Asheesh K. Dewan, David R. Liljenquist, Yogish C. Kudva, Fang Niu, Caroline Yovanovich, John J. Shin, Toni L. Cordero, Jennifer J.F. McVean, Robert A. Vigersky, Richard M. Bergenstal

    Erschienen: 2026-11-01DOI: 10.1177/15209156261444994

  3. Increased Glycation Ratio and Risk of Complications in Latent Autoimmune Diabetes in Adults Compared With Type 1 Diabetes Onset before 30 Years: A Cohort Study

    Sandra Herranz-Antolín, Fernando Gómez-Peralta, Xu Yongjin, María Asunción Martínez-Brocca, Gloria Cánovas-Molina, Aurora Aragón-Alonso, Miguel Brito-Sanfiel, Jose Ignacio Martínez-Montoro, Virginia Bellido, Sharona Azriel, María del Carmen López-García, Cristina Tejera, Amparo Bartual, Verónica Perea, Pedro José Pines, Antonio J. Amor, Óscar Moreno-Pérez, Rebeca Reyes-García, Gema López-Gallardo, María Durán-Martínez, Cristina Serrano, Rosa Márquez-Pardo, Noemí González-Pérez de Villar, Manuel Gargallo, Estefanía Santos, Pedro Pujante, Jessica Ares, Diego Bellido, Ignacio Conget, Yaghoub Dabiri, Timothy C. Dunn

    Erschienen: 2026-11-01DOI: 10.1177/15209156261451052

  4. Sustained Follow-up of Automated Insulin Delivery in a Real-World Setting: Results at 2 Years of the French Nationwide Observatory OB2F

    Jean-Baptiste Julla, Chloé Amouyal, Sandrine Lablanche, Agnès Sola Gazagnes, Michael Joubert, Samy Hadjadj, Candace Ben Signor, Elise Bismuth, Yannis Chartier, Nathalie Garrec, Joëlle Dupont, Emma Carreira, René Valéro, Gaëtan Prévost, Rosine Guintrand, Florent Verdier, Carole Legagneur, Jacques Beltrand, Anne-Cécile Paepegaey, Alina Radu, Jean-François Gautier, Éric Renard, Jean-Pierre Riveline

    Erschienen: 2026-07-10DOI: 10.1177/15209156261465478

  5. Cost–Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes

    Jolien De Meulemeester, Francesca Fiorentino, Nuno Picado, Margaretha M. Visser, Bart Keymeulen, Christophe De Block, Liesbeth Van Huffel, Youri Taes, Dominique Ballaux, Katrien Spincemaille, Joke Marlier, Gerd Vanhaverbeke, Ine Lowyck, Chris Vercammen, Ides M. Colin, Vanessa Preumont, Chantal Mathieu, Jeroen Luyten, Sharon M. Wang, Bimal V. Patel, Jordan E. Pinsker, Pieter Gillard

    Erschienen: 2026-07-01DOI: 10.1177/15209156251408041

  6. Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use

    Satish K. Garg, Halis K. Akturk, Samita Garg, Roy W. Beck, Natalie J. Bellini, Petter Bjornstad, Anders L. Carlson, Jim Carroll, Kelly Close, Christophe De Block, Klemen Dovc, Gregory P. Forlenza, Francesco Giorgino, Julie Heverly, Irl B. Hirsch, Mareda Lewer, Brynn E. Marks, Chantal Mathieu, Revital Nimri, Christie Beatson, Kirsten Nørgaard, David N. O’Neal, Francisco J. Pasquel, Moshe Phillip, Sarit Polsky, Banshi Saboo, Viral N. Shah, Hui Shao, Jennifer L. Sherr, Janet K. Snell-Bergeon, Kohjiro Ueki, Tadej Battelino

    Erschienen: 2026-06-05DOI: 10.1177/15209156261449879

Jahrgänge

2026 · 1952025 · 1952024 · 1552023 · 1472022 · 1452021 · 1522020 · 1472019 · 1322018 · 1422017 · 1542016 · 1562015 · 1592014 · 1462013 · 1802012 · 1992011 · 1772010 · 1592009 · 1462008 · 802007 · 782006 · 832005 · 1252004 · 1112003 · 1072002 · 982001 · 742000 · 951999 · 78

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.